[go: up one dir, main page]

DK1289955T3 - Piperidines for use as orexin receptor antagonists - Google Patents

Piperidines for use as orexin receptor antagonists

Info

Publication number
DK1289955T3
DK1289955T3 DK01951591T DK01951591T DK1289955T3 DK 1289955 T3 DK1289955 T3 DK 1289955T3 DK 01951591 T DK01951591 T DK 01951591T DK 01951591 T DK01951591 T DK 01951591T DK 1289955 T3 DK1289955 T3 DK 1289955T3
Authority
DK
Denmark
Prior art keywords
piperidines
receptor antagonists
orexin receptor
orexin
antagonists
Prior art date
Application number
DK01951591T
Other languages
Danish (da)
Inventor
Clive Leslie Branch
Christopher Norbert Johnson
Geoffrey Stemp
Kevin Thewlis
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0014823A external-priority patent/GB0014823D0/en
Priority claimed from GB0027704A external-priority patent/GB0027704D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority claimed from PCT/EP2001/006752 external-priority patent/WO2001096302A1/en
Application granted granted Critical
Publication of DK1289955T3 publication Critical patent/DK1289955T3/en

Links

DK01951591T 2000-06-16 2001-06-13 Piperidines for use as orexin receptor antagonists DK1289955T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0014823A GB0014823D0 (en) 2000-06-16 2000-06-16 Compounds
GB0027704A GB0027704D0 (en) 2000-11-11 2000-11-11 Compounds
PCT/EP2001/006752 WO2001096302A1 (en) 2000-06-16 2001-06-13 Piperidines for use as orexin receptor antagonists
EP01951591A EP1289955B1 (en) 2000-06-16 2001-06-13 Piperidines for use as orexin receptor antagonists

Publications (1)

Publication Number Publication Date
DK1289955T3 true DK1289955T3 (en) 2005-08-01

Family

ID=34811641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01951591T DK1289955T3 (en) 2000-06-16 2001-06-13 Piperidines for use as orexin receptor antagonists

Country Status (1)

Country Link
DK (1) DK1289955T3 (en)

Similar Documents

Publication Publication Date Title
NO20040028L (en) Substituted aniline piperidines as MCH-selective antagonists
ATE368659T1 (en) THROMBIN RECEPTOR ANTAGONISTS
DK1571145T3 (en) Substituted piperidine compounds for use as H3 histamine receptor antagonists
NO20021450L (en) Cyclic amine compounds as CCR5 antagonists
DK1309559T3 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
DK1501809T3 (en) Trizole derivatives as tachykinin receptor antagonists
DK1682142T3 (en) M3-muscarinic acetylcholine receptor antagonists
NO20035739L (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
DK2208727T3 (en) Diarylethers as opioid receptor antagonists
NO20015365D0 (en) Piperidine derivatives useful as CCR5 antagonists
DE602004030930D1 (en) MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
NO20052739D0 (en) CCR5 antagonists as drugs
NO20050429D0 (en) Substituted quinoline CCR5 receptor antagonists
NO20023485D0 (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
NO20030471D0 (en) Carboxamide compounds and their use as antagonists for an 11CBY receptor
IL174538A0 (en) Thrombin receptor antagonists
DK1305319T3 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
NO20041266L (en) Piperidine derivatives which can be used as CCR5 antagonists
NO20025640L (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
DK1360184T3 (en) Piperidine derivatives as neurokinin-1 antagonists
DE602005004011D1 (en) HYDROISOINDOLIN tachykinin receptor antagonists
NO20004261L (en) 2-arylethyl (piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists
NO20004668D0 (en) 1- (3-heteroarylpropyl- or -prop-2-enyl) -4-benzylpiperidines used as NMDA receptor antagonists
ATE469875T1 (en) NK1 ANTAGONISTS
DK1648882T3 (en) 3-fluoro-piperidines as NMDA / NR2B antagonists